F2G Company
F2G discovers and develops novel drugs for the treatment of life-threatening fungal diseases.
Industry:
PharmTech
Headquarters:
Manchester, Manchester, United Kingdom
Founded Date:
1998
Employees Number:
251-500
Funding Status:
Venture Capital-Backed
Investors Number:
18
Total Funding:
£166 346 439
Estimated Revenue:
$10M to $50M
Last Funding Date:
8/12/2020
Last Funding Type:
Venture - Series Unknown
Register and Claim Ownership